Publication related to RSI or an RSI staff member

Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies.

Benzene is considered a carcinogen, mostly based on evidence of causality for myeloid leukemia from high levels of exposure in occupational studies. We used United States Environmental Protection Agency National Ambient Toxics Assessment (NATA) estimates of low-level ambient benzene to examine potential associations for the general public between benzene exposure and risk of hematologic cancers. Exposure was estimated by linking participants’ residential address to the NATA benzene estimates for that census tract. Among 115,996 American Cancer Society Cancer Prevention Study-II Nutrition cohort participants (52,554 men, 63,442 women), 2,595 were diagnosed with incident hematologic cancer between 1997 and 2013. Extended Cox regression modeling was used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Among all participants, ambient benzene was positively associated with myelodysplastic syndromes (HR = 1.16, 95% CI: 1.01-1.33 per mug/m(3) ) and T-cell lymphoma (HR = 1.29, 95% CI: 1.08-1.53 per mug/m(3) ). Among men, ambient benzene was also positively associated with any hematologic malignancy (HR = 1.07, 95% CI: 1.01-1.15 per mug/m(3) ) and follicular lymphoma (HR = 1.28, 95% CI: 1.09-1.50 per mug/m(3) ). No significant associations were observed for women only, but associations were suggestive for MDS and T-cell lymphoma. It is possible that the NATA ambient benzene estimates are a better proxy for benzene exposure for men than women in this cohort. The results of this study support an association between ambient benzene and risk of hematologic malignancies, particularly MDS, T-cell lymphoma and follicular lymphoma. More research in large scale or pooled studies is needed to further explore these associations.

Authors

  • Teras, Lauren R, Teras LR, Epidemiology Research Group, American Cancer Society, Atlanta, GA.

  • Diver, W Ryan, Diver WR, Epidemiology Research Group, American Cancer Society, Atlanta, GA.

  • Deubler, Emily L, Deubler EL, Epidemiology Research Group, American Cancer Society, Atlanta, GA.

  • Krewski, Daniel, Krewski D, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.; School of Epidemiology, Public Health and Disease Prevention, University of Ottawa, Ottawa, ON, Canada.

  • Flowers, Christopher R, Flowers CR, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

  • Switchenko, Jeffrey M, Switchenko JM, Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.

  • Gapstur, Susan M, Gapstur SM, Epidemiology Research Group, American Cancer Society, Atlanta, GA.

YEAR OF PUBLICATION: 2019
SOURCE: Int J Cancer. 2019 Nov 15;145(10):2647-2660. doi: 10.1002/ijc.32202. Epub 2019 Feb 27.
JOURNAL TITLE ABBREVIATION: Int J Cancer
JOURNAL TITLE: International journal of cancer
ISSN: 1097-0215 (Electronic) 0020-7136 (Linking)
VOLUME: 145
ISSUE: 10
PAGES: 2647-2660
PLACE OF PUBLICATION: United States
ABSTRACT:
Benzene is considered a carcinogen, mostly based on evidence of causality for myeloid leukemia from high levels of exposure in occupational studies. We used United States Environmental Protection Agency National Ambient Toxics Assessment (NATA) estimates of low-level ambient benzene to examine potential associations for the general public between benzene exposure and risk of hematologic cancers. Exposure was estimated by linking participants' residential address to the NATA benzene estimates for that census tract. Among 115,996 American Cancer Society Cancer Prevention Study-II Nutrition cohort participants (52,554 men, 63,442 women), 2,595 were diagnosed with incident hematologic cancer between 1997 and 2013. Extended Cox regression modeling was used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Among all participants, ambient benzene was positively associated with myelodysplastic syndromes (HR = 1.16, 95% CI: 1.01-1.33 per mug/m(3) ) and T-cell lymphoma (HR = 1.29, 95% CI: 1.08-1.53 per mug/m(3) ). Among men, ambient benzene was also positively associated with any hematologic malignancy (HR = 1.07, 95% CI: 1.01-1.15 per mug/m(3) ) and follicular lymphoma (HR = 1.28, 95% CI: 1.09-1.50 per mug/m(3) ). No significant associations were observed for women only, but associations were suggestive for MDS and T-cell lymphoma. It is possible that the NATA ambient benzene estimates are a better proxy for benzene exposure for men than women in this cohort. The results of this study support an association between ambient benzene and risk of hematologic malignancies, particularly MDS, T-cell lymphoma and follicular lymphoma. More research in large scale or pooled studies is needed to further explore these associations.
COPYRIGHT INFORMATION: (c) 2019 UICC.
LANGUAGE: eng
DATE OF PUBLICATION: 2019 Nov 15
DATE OF ELECTRONIC PUBLICATION: 20190227
DATE COMPLETED: 20200217
DATE REVISED: 20200217
MESH DATE: 2020/02/18 06:00
EDAT: 2019/02/10 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1002/ijc.32202 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski